Rhenman & Partners Asset Management AB - Q4 2019 holdings

$913 Million is the total value of Rhenman & Partners Asset Management AB's 94 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 0.0% .

 Value Shares↓ Weighting
AMRN  AMARIN CORP PLCspons adr new$8,576,000
+41.4%
400,0000.0%0.94%
+23.7%
ABEO  ABEONA THERAPEUTICS INC$3,270,000
+44.7%
1,000,0000.0%0.36%
+26.5%
VKTX  VIKING THERAPEUTICS INC$1,604,000
+16.6%
200,0000.0%0.18%
+2.3%
PIRS  PIERIS PHARMACEUTICALS INC$1,086,000
+6.2%
300,0000.0%0.12%
-7.0%
CVX  CHEVRON CORP$358,000
+1.4%
2,9740.0%0.04%
-11.4%
QCOM  QUALCOMM INC$299,000
+15.4%
3,3910.0%0.03%
+3.1%
DIS  DISNEY WALT CO$301,000
+11.1%
2,0830.0%0.03%
-2.9%
IBM  INTERNATIONAL BUSINESS MACHS$297,000
-7.8%
2,2150.0%0.03%
-17.5%
WFC  WELLS FARGO CO NEW$284,000
+6.8%
5,2720.0%0.03%
-6.1%
F  FORD MTR CO DEL$271,000
+1.5%
29,1640.0%0.03%
-9.1%
XOM  EXXON MOBIL CORP$269,000
-1.1%
3,8540.0%0.03%
-14.7%
JHG  JANUS HENDERSON GROUP PLC$260,000
+8.8%
10,6450.0%0.03%
-6.7%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-01-17
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
UNITEDHEALTH GROUP INC40Q3 20234.0%
BIOMARIN PHARMACEUTICAL INC40Q3 20235.0%
ALKERMES PLC40Q3 20233.3%
LILLY ELI & CO39Q3 20235.8%
CVS HEALTH CORP39Q3 20233.5%
INTRA-CELLULAR THERAPIES INC39Q3 20232.4%
EDWARDS LIFESCIENCES CORP39Q3 20231.7%
VERTEX PHARMACEUTICALS INC38Q3 20234.3%
REVANCE THERAPEUTICS INC38Q3 20230.9%
ABBVIE INC37Q3 20234.4%

View Rhenman & Partners Asset Management AB's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-13
13F-HR/A2023-11-13
13F-HR2023-11-09
13F-HR2023-08-11
13F-HR2023-05-12
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-12
13F-HR2022-05-13
13F-HR2022-02-11

View Rhenman & Partners Asset Management AB's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (912509000.0 != 912515000.0)

Export Rhenman & Partners Asset Management AB's holdings